Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Objective: Approximately 50% to 70% of breast cancer survivors are affected by one or more symptoms of vulvovaginal atrophy (VVA). For those who cannot take hormone therapy, autologous platelet-rich plasma combined with hyaluronic acid (A-PRP-HA) may provide a new alternative therapy for the treatment of VVA in postmenopausal women with history of breast cancer. Methods: We enrolled 20 postmenopausal breast cancers survivors with VVA and a score of <15 on the Gloria Bachman Vaginal Health Index (VHI) comprised of five items including: vaginal pH, elasticity, fluid volume (secretions), epithelial integrity, and moisture. We administered intramucosal injections of A-PRP combined with HA (Regenkit) and performed clinical evaluations at 0, 1, 3, and 6 months. Primary endpoint: evaluation of vulvovaginal mucosa changes using the VHI; secondary endpoint: evaluation of dyspareunia and sexual dysfunction based on the Female Sexual Distress (FSD) score. Results: All participants (20 women) showed improvement in the clinical symptoms of vaginal dryness and dyspareunia. The VHI score showed a significant increase at 6 months, going from a total baseline score (pretreatment) of 10.7 ± 2.12 to 20.75 ± 4.8 ( P < 0.0001) at 6 months. Improvement in hydration and vaginal epithelial integrity was reported. A VHI score of > 15 showed a successful treatment outcome. The FSD score decreased significantly during the study, from a baseline score of 36.35 ± 2.53 pretreatment to 30.15 ± 2.47 6 months after treatment, representing improvement of 17% ( P < 0.0001, respectively). No adverse events were reported. Conclusions: The injection of A-PRP-HA appeared to be a promising method to improve the trophicity and hydration of vaginal mucosa for the treatment of VVA in postmenopausal breast cancer survivors with contraindications to hormone therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The value of local testosterone application and of invasive measures like vaginal laser or hyaluronic acid injections is still unclear.133, 134, 135”
From 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) (2020) · cites this paper as [134]
Citations
Cites
The 2012 Hormone Therapy Position Statement of The North American Menopause Society
(2012) · Menopause · doi:10.1097/gme.0b013e31824b970a · Cited by 785
DeRogatis, L., Clayton, A., Lewis-D'Agostino, D., Wunderlich, G., & Fu, Y. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00672.x · Cited by 740
Fakhari, A., & Berkland, C. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.03.005 · Cited by 518
Kakudo, N., Minakata, T., Mitsui, T., Kushida, S., Notodihardjo, F. Z., & Kusumoto, K. (2008) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0b013e3181882046 · Cited by 348
Platelet-rich plasma: support for its use in wound healing.
Lacci, K. M., & Dardik, A. (2010) · PubMed · Cited by 343
Levine, K. B., Williams, R. E., & Hartmann, K. E. (2008) · Menopause · doi:10.1097/gme.0b013e31815a5168 · Cited by 296
Tadir, Y., Gaspar, A., Lev‐Sagie, A., Alexiades, M., Alinsod, R., Bader, A., Calligaro, A., Elias, J. A., Gambaciani, M., Gaviria, J. E., et al. (2017) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22637 · Cited by 244
Urogenital ageing: an old problem newly recognized
Bachmann, G. (1995) · Maturitas · doi:10.1016/0378-5122(95)00956-6 · Cited by 233
Age-Dependent Changes of Hyaluronan in Human Skin
Meyer, L. J. M., & Stern, R. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371800 · Cited by 219
In vitro release of vascular endothelial growth factor during platelet aggregation
Maloney, J. P., Silliman, C. C., Ambruso, D. R., Wang, J., Tuder, R. M., & Voelkel, N. F. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.275.3.h1054 · Cited by 218
Research works printed but not linked: 2
- Guerid, 2013, Autologous keratinocyte suspension in platelet concentrate accelerates and enhances wound healing - a prospective randomized clinical trial on skin graft donor sites: platelet concentrate and keratinocytes on donor sites, Fibrogenesis Tissue Repair, 6, 8, 10.1186/1755-1536-6-8 · DOI
- Charles Runels, 2014, Ernest Debourbon and Lisbeth Roy, J Women's Health Care, 3, 4
Cited by
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Cardoso, F., Costa, A., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Bhattacharyya, G., Biganzoli, L., Cardoso, M. J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw544 · Cited by 2,033
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
Cardoso, F., Paluch-Shimon, S., Senkus, E., Curigliano, G., Aapro, M. S., André, F., Barrios, C. H., Bergh, J., Bhattacharyya, G. S., Biganzoli, L., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.09.010 · Cited by 1,369
“The value of local testosterone application and of invasive measures like vaginal laser or hyaluronic acid injections is still unclear.(133-135) In summary, gynaecological and sexual symptoms are important challenges for most ABC patients.”
BackgroundScavello, I., Maseroli, E., Di Stasi, V., & Vignozzi, L. (2019) · Medicina · doi:10.3390/medicina55090559 · Cited by 184
“In 2018 a phase 2 pilot study was conducted to investigate the efficacy of autologous platelet-rich plasma combined with hyaluronic acid for the treatment of VVA in 20 postmenopausal women with a history of breast cancer [87].”
BackgroundManagement of genitourinary syndrome of menopause in breast cancer survivors: An update
López, D. M. L. (2022) · World Journal of Clinical Oncology · doi:10.5306/wjco.v13.i2.71 · Cited by 112
Hersant, B., Werkoff, G., Sawan, D., SidAhmed‐Mezi, M., Bosc, R., Padula, S. L., Kalsoum, S., Ouidir, N., Meningaud, J., & Belkacémi, Y. (2020) · Annales de Chirurgie Plastique Esthétique · doi:10.1016/j.anplas.2020.05.002 · Cited by 77
Self-citation
Metadata
- Authors
- Hersant, B., SidAhmed-Mezi, M., Belkacemi, Y., Darmon, F., Bastuji-Garin, S., Werkoff, G., Bosc, R., Niddam, J., Hermeziu, O., La Padula, S., & Meningaud, J. P.
- Affiliations
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- Department of Maxillofacial and Plastic & Reconstructive Surgery, Henri Mondor University Hospital, Créteil, France
- Henri Mondor Breast Center, Henri Mondor Hospital, Creteil, France
- AP-HP, Hospital Henri Mondor, Department of Public Health and Clinical Research Unit (URC Mondor), Créteil cedex, France
- Corresponding author
- Hersant, Barbara
- Venue
- Menopause
- Published
- 2018-10
- Volume
- 25
- Issue
- 10
- Pages
- 1124-1130
- ISSN
- 1072-3714 (ISSN-L)
- 1530-0374
- OpenAlex
- W2911861105
- Cited by
- 86
- References
- 38
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 11 · 2023: 14 · 2022: 16 · 2021: 9 · 2020: 8 · 2019: 4 · 2018: 1
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Menopause The Journal of The North American Menopause Society (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
- Keywords
- vaginal atrophy, breast cancer survivors, autologous platelet-rich plasma, hyaluronic acid, postmenopausal women, vaginal dryness, dyspareunia, female sexual dysfunction, non-hormonal therapy
- MeSH terms
- Cancer Survivors, Adjuvants, Immunologic, Aged, Complementary Therapies, Analysis of Variance, Atrophy, Breast Neoplasms, Female, Follow-Up Studies, France, Hospitals, University, Humans, Hyaluronic Acid, Middle Aged, Pilot Projects, Prospective Studies, Sexual Dysfunction, Physiological, Vagina, Vulva, Treatment Outcome, Patient Satisfaction, Postmenopause, Regenerative Medicine, Platelet-Rich Plasma, Administration, Mucosal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study. https://app.cochat.ai/papers/10.1097/gme.0000000000001122
- The paper
- Hersant, B., SidAhmed-Mezi, M., Belkacemi, Y., Darmon, F., Bastuji-Garin, S., Werkoff, G., Bosc, R., Niddam, J., Hermeziu, O., La Padula, S., & Meningaud, J. P. (2018). Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study. Menopause. https://doi.org/10.1097/gme.0000000000001122
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.